Clinical Trial Update: SB-742457 And Donepezil In Alzheimer's Disease [Phase 2]

View source ↗

Summary

This document reports a Phase 2 trial evaluating SB-742457 in combination with donepezil for Alzheimer's disease. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Donepezil (donepezil)
• SB-742457

Snippet

Sponsor: GlaxoSmithKline | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED